IGF-LR3
Description
A synthetic, long-acting analog of Insulin-Like Growth Factor 1 engineered with a 13-amino acid N-terminal extension and an Arg3 substitution, widely researched for its potent anabolic activity and extended receptor binding capability.
Available in 0.1mg–1mg vials, every lot is third-party tested for identity and purity, with certificates of analysis available on request. Vials arrive sealed and sterile, lyophilized for stability, and ship from our U.S. facility in 2–6 days.
For in vitro laboratory research use only. See the Technical Data tab below for the full mechanism and feature summary.
IGF-LR3 from Wolf Research is a high-purity research-grade compound intended strictly for laboratory research use.
IGF-LR3 (Long R3 IGF-1 (Insulin-like Growth Factor-1,Long Arg3 analog)) is supplied as a research-grade peptide for in vitro study. Synthetic research peptides of this class are widely used in laboratory studies of receptor signaling, tissue biology, and peptide pharmacology.
Every lot of IGF-LR3 is third-party tested for identity and purity, with certificates of analysis available on request. Supplied in sealed, sterile vials and shipped fast from our U.S. facility.
The products offered herein are intended exclusively for research purposes and must be utilized solely within in vitro environments (e.g., test tubes or laboratory settings) for the purposes of testing and experimentation. All information provided on this website is strictly for educational purposes and does not constitute legal or professional advice. It is imperative to acknowledge that the introduction of these products into humans or animals, in any capacity, is strictly prohibited by applicable laws and regulations. Violation of these regulations may result in legal repercussions. These products are intended solely for use by qualified, licensed professionals with the expertise to handle them safely and responsibly. Furthermore, it is important to note that these products are not classified as drugs, food, or cosmetics under any legal definitions. Any misbranding, misuse, or mislabeling of these products within these categories is expressly prohibited and may lead to further legal consequences. By adhering to these guidelines, you ensure compliance with all regulatory frameworks and contribute to the responsible conduct of scientific research.
Technical Data
| A synthetic, long-acting analog of Insulin-Like Growth Factor 1 engineered with a 13-amino acid N-terminal extension and an Arg3 substitution, widely researched for its potent anabolic activity and extended receptor binding capability. | |
|---|---|
| Key Benefits & Highlights | |
| Extended Biological Half-Life | Features an Arg3 substitution that drastically reduces binding to IGF-binding proteins (IGFBPs), allowing greater bioavailability and prolonged receptor interaction. |
| Enhanced Cellular Hypertrophy | Researched in cell culture models for its ability to stimulate protein synthesis, satellite cell activation, and localized muscle cell proliferation. |
| Nutrient Partitioning & Uptake | Investigated for its role in modulating glucose and amino acid transport into muscular tissue, supporting cellular bioenergetics research. |
| High Chemical Purity | Synthesized to stringent analytical standards to ensure exact amino acid sequence fidelity and minimal experimental variance. |
| Standardized Research Reagent | Formulated for reliable reproducibility across in vitro growth factor assays, receptor kinetic studies, and cellular proliferation research. |
| Feature Summary | |
| Product Class | Synthetic Insulin-Like Growth Factor-1 Analog / Recombinant Peptide |
| Primary Application | In vitro cellular proliferation, protein synthesis & growth factor pathway research |
| Grade | Laboratory / Research Grade Only |